Detalhe da pesquisa
1.
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
N Engl J Med;
389(8): 687-699, 2023 Aug 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37486775
2.
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
N Engl J Med;
385(7): 595-608, 2021 08 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34379922
3.
Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV).
Clin Infect Dis;
76(3): e571-e579, 2023 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36049028
4.
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study.
Clin Infect Dis;
76(9): 1646-1654, 2023 05 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36660819
5.
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
Clin Infect Dis;
76(3): e613-e621, 2023 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35975297
6.
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States.
Clin Infect Dis;
76(2): 323-334, 2023 01 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36101518
7.
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.
N Engl J Med;
382(12): 1124-1135, 2020 03 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32130806
8.
COVID-19 Vaccination Rates in a Global HIV Cohort.
J Infect Dis;
225(4): 603-607, 2022 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34794178
9.
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.
J Infect Dis;
226(10): 1809-1822, 2022 11 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35535576
10.
Bacterial Sexually Transmitted Infection Incidence Among Southern Men Who Have Sex With Men With Human Immunodeficiency Virus in the Treatment as Prevention Era, 2014-2019.
Clin Infect Dis;
75(8): 1446-1448, 2022 10 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35380640
11.
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus.
Clin Infect Dis;
74(1): 95-104, 2022 01 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33693561
12.
Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk.
Clin Infect Dis;
75(7): 1154-1163, 2022 09 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35165682
13.
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy.
Clin Infect Dis;
75(8): 1324-1333, 2022 10 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35235653
14.
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.
Lancet;
396(10267): 1994-2005, 2021 12 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33308425
15.
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.
Clin Infect Dis;
73(11): 2009-2022, 2021 12 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34134131
16.
Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients.
Am J Transplant;
21(3): 938-949, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32885604
17.
Physical Function Impairment and Frailty in Middle-Aged People Living With Human Immunodeficiency Virus in the REPRIEVE Trial Ancillary Study PREPARE.
J Infect Dis;
222(Suppl 1): S52-S62, 2020 07 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32645163
18.
An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.
J Infect Dis;
222(Suppl 1): S41-S51, 2020 07 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32645164
19.
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
J Infect Dis;
222(Suppl 1): S8-S19, 2020 07 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32645162
20.
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.
N Engl J Med;
375(21): 2037-2050, 2016 11 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27959728